We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of CEROW yet.

CEROW Hedge Fund Activity: Q1 2026 in Review

1 of the 8,143 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2026, worth a combined $11 — down 50% from $22 a quarter earlier.

Fund positioning in CEROW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held CERo Therapeutics Warrants (CEROW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $11 of CERo Therapeutics Warrants stock for Q1 2026, down 50% quarter-over-quarter.
  • 0 funds opened new CERo Therapeutics Warrants positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.